Barclays PLC Athenex, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.41 - $0.91 $5,755 - $12,774
-14,038 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.79 - $1.59 $71,827 - $144,564
-90,921 Reduced 86.63%
14,038 $12,000
Q4 2021

Feb 14, 2022
BUY
$1.36 - $2.94 $92,606 - $200,193
68,093 Added 184.7%
104,959 $143,000
Q3 2021

Nov 09, 2021
SELL
$2.97 - $4.84 $75,075 - $122,345
-25,278 Reduced 40.68%
36,866 $111,000
Q2 2021

Aug 13, 2021
SELL
$3.71 - $5.13 $179,170 - $247,748
-48,294 Reduced 43.73%
62,144 $287,000
Q1 2021

May 13, 2021
BUY
$4.08 - $14.75 $142,889 - $516,574
35,022 Added 46.44%
110,438 $475,000
Q4 2020

Feb 11, 2021
SELL
$11.06 - $14.01 $26,311 - $33,329
-2,379 Reduced 3.06%
75,416 $833,000
Q3 2020

Nov 12, 2020
BUY
$10.26 - $14.55 $357,048 - $506,340
34,800 Added 80.94%
77,795 $942,000
Q2 2020

Aug 12, 2020
BUY
$7.11 - $13.76 $90,389 - $174,930
12,713 Added 41.98%
42,995 $592,000
Q1 2020

May 13, 2020
SELL
$5.71 - $15.85 $414,939 - $1.15 Million
-72,669 Reduced 70.59%
30,282 $234,000
Q4 2019

Feb 10, 2020
SELL
$9.6 - $17.75 $282,604 - $522,524
-29,438 Reduced 22.24%
102,951 $1.57 Million
Q3 2019

Nov 14, 2019
BUY
$12.16 - $21.0 $777,255 - $1.34 Million
63,919 Added 93.35%
132,389 $1.61 Million
Q2 2019

Aug 14, 2019
BUY
$9.44 - $19.8 $528,120 - $1.11 Million
55,945 Added 446.67%
68,470 $1.36 Million
Q1 2019

May 15, 2019
BUY
$11.11 - $13.49 $139,152 - $168,962
12,525 New
12,525 $153,000
Q4 2018

Feb 14, 2019
SELL
$10.24 - $15.49 $227,543 - $344,203
-22,221 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$15.53 - $19.97 $297,166 - $382,125
19,135 Added 620.06%
22,221 $345,000
Q2 2018

Aug 14, 2018
SELL
$15.88 - $19.5 $44,892 - $55,126
-2,827 Reduced 47.81%
3,086 $58,000
Q1 2018

May 15, 2018
BUY
$13.53 - $17.47 $64,808 - $83,681
4,790 Added 426.54%
5,913 $100,000
Q4 2017

Feb 14, 2018
SELL
$14.41 - $19.15 $79,024 - $105,018
-5,484 Reduced 83.0%
1,123 $18,000
Q3 2017

Nov 14, 2017
BUY
$13.5 - $19.51 $89,194 - $128,902
6,607
6,607 $116,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email